Breaking News Instant updates and real-time market news.

TECH

Bio-Techne

$190.63

-1.52 (-0.79%)

09:16
08/13/19
08/13
09:16
08/13/19
09:16

Bio-Techne and Cygnus Technologies announce partnership

Bio-Techne and Cygnus Technologies, part of Maravai LifeSciences, announced a strategic partnership for the quantification of Chinese hamster ovary host cell proteins, or CHO-HCP, on the ProteinSimple-branded Ella immunoassay platform. Under the terms of the agreement, Bio-Techne and Cygnus are introducing the co-developed third generation CHO-HCP assay in the proprietary Simple Plex immunoassay cartridge for customers in North America and Europe.

  • 13

    Nov

TECH Bio-Techne
$190.63

-1.52 (-0.79%)

02/06/19
CHLM
02/06/19
NO CHANGE
Target $179
CHLM
Hold
Bio-Techne price target raised to $179 from $154 at Craig-Hallum
Craig-Hallum analyst Alexander Nowak raised his price target for Bio-Techne to $179 from $154 after a strong quarter from its Protein Sciences business and better cost control. The analyst reiterates a Hold rating on the shares.
03/04/19
ARGS
03/04/19
NO CHANGE
Target $230
ARGS
Bio-Techne on track for continued solid revenue growth, says Argus
Argus analyst David Toung believes Bio-Techne remains on-track for continued solid revenue growth driven by strong domestic and international demand for its products. He lowered his estimates to reflect earnings dilution from its recent acquisition, but noted the company is targeting $1B in revenues by 2022. Toung reiterated his Buy rating and $230 price target on Bio-Techne shares.
06/03/19
BARD
06/03/19
NO CHANGE
Target $222
BARD
Outperform
Bio-Techne designated as a Fresh Pick at Baird
Baird analyst Catherine Ramsey Schulte designated Bio-Techne as a Fresh Pick following its update for the Prostate Cancer Early Detection guidelines, with the discussion section including positive positioning for EPI. She said she would be adding to positions ahead of expected Medicare progress in June. Ramsey Schulte reiterated her Outperform rating and $222 price target on Bio-Techne shares.
07/02/19
JANY
07/02/19
UPGRADE
Target $270
JANY
Buy
Bio-Techne upgraded to Buy from Neutral at Janney Montgomery Scott
Janney Montgomery Scott upgraded Bio-Techne to Buy and raised its price target to $270 from $200.

TODAY'S FREE FLY STORIES

HCAT

Health Catalyst

$42.50

0.96 (2.31%)

06:35
08/19/19
08/19
06:35
08/19/19
06:35
Initiation
Health Catalyst initiated  »

Health Catalyst initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

HCAT

Health Catalyst

$42.50

0.96 (2.31%)

06:33
08/19/19
08/19
06:33
08/19/19
06:33
Initiation
Health Catalyst initiated  »

Health Catalyst initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

HCAT

Health Catalyst

$42.50

0.96 (2.31%)

06:32
08/19/19
08/19
06:32
08/19/19
06:32
Initiation
Health Catalyst initiated  »

Health Catalyst initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

HCAT

Health Catalyst

$42.50

0.96 (2.31%)

06:31
08/19/19
08/19
06:31
08/19/19
06:31
Initiation
Health Catalyst initiated  »

Health Catalyst initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

WLL

Whiting Petroleum

$8.61

0.36 (4.36%)

06:30
08/19/19
08/19
06:30
08/19/19
06:30
Downgrade
Whiting Petroleum rating change  »

Whiting Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 08

    Oct

  • 09

    Oct

ARCC

Ares Capital

$18.63

0.27 (1.47%)

06:29
08/19/19
08/19
06:29
08/19/19
06:29
Upgrade
Ares Capital rating change  »

Ares Capital upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTVA

Corteva

$30.25

1.84 (6.48%)

06:26
08/19/19
08/19
06:26
08/19/19
06:26
Upgrade
Corteva rating change  »

Corteva upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$183.42

0.78 (0.43%)

, ACN

Accenture

$193.19

3.675 (1.94%)

06:25
08/19/19
08/19
06:25
08/19/19
06:25
Periodicals
Facebook content moderation firm sought counseling details, The Intercept says »

A Facebook (FB) content…

FB

Facebook

$183.42

0.78 (0.43%)

ACN

Accenture

$193.19

3.675 (1.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 24

    Sep

  • 26

    Sep

  • 27

    Oct

PROS

ProSight

$18.71

-0.5 (-2.60%)

06:23
08/19/19
08/19
06:23
08/19/19
06:23
Initiation
ProSight initiated  »

ProSight initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$206.44

4.71 (2.33%)

06:23
08/19/19
08/19
06:23
08/19/19
06:23
Periodicals
Apple CEO Cook has met Trump 'at least' 5 times in a year, BI reports »

Apple CEO Tim Cook has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

POL

PolyOne

$31.01

0.73 (2.41%)

06:21
08/19/19
08/19
06:21
08/19/19
06:21
Earnings
PolyOne raises FY19 adj. EPS view to up 6%-8% from up 4%-6%, consensus $2.54 »

Guidance reflects the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

AMZN

Amazon.com

$1,791.82

16.72 (0.94%)

06:20
08/19/19
08/19
06:20
08/19/19
06:20
Periodicals
Amazon beats IRS appeal in U.S. tax dispute, Reuters reports »

Amazon on Friday defeated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

ARMK

Aramark

$37.07

-0.07 (-0.19%)

06:19
08/19/19
08/19
06:19
08/19/19
06:19
Upgrade
Aramark rating change  »

Aramark upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$203.95

4.74 (2.38%)

06:19
08/19/19
08/19
06:19
08/19/19
06:19
Downgrade
Amgen rating change  »

Amgen downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 16

    Sep

  • 19

    Sep

POL

PolyOne

$31.01

0.73 (2.41%)

06:18
08/19/19
08/19
06:18
08/19/19
06:18
Hot Stocks
PolyOne to sell PP&S business to SK Capital Partners for $775M in cash »

PolyOne announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

CNHI

CNH Industrial

$8.82

0.18 (2.08%)

06:18
08/19/19
08/19
06:18
08/19/19
06:18
Upgrade
CNH Industrial rating change  »

CNH Industrial upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENLC

EnLink Midstream

$7.74

0.19 (2.52%)

06:17
08/19/19
08/19
06:17
08/19/19
06:17
Downgrade
EnLink Midstream rating change  »

EnLink Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 06

    Nov

HEP

Holly Energy Partners

$27.48

0.31 (1.14%)

06:17
08/19/19
08/19
06:17
08/19/19
06:17
Downgrade
Holly Energy Partners rating change  »

Holly Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$89.46

0.91 (1.03%)

06:17
08/19/19
08/19
06:17
08/19/19
06:17
Periodicals
Novartis to respond to demand for data manipulation details, Reuters says »

Novartis plans to answer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 25

    Sep

GOOG

Alphabet

$1,176.94

9.48 (0.81%)

, GOOGL

Alphabet Class A

$1,178.69

9.68 (0.83%)

06:15
08/19/19
08/19
06:15
08/19/19
06:15
Periodicals
Google cuts some Android phone data for wireless carriers, Reuters reports »

Google has shut down its…

GOOG

Alphabet

$1,176.94

9.48 (0.81%)

GOOGL

Alphabet Class A

$1,178.69

9.68 (0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Oct

EWBC

East West Bancorp

$39.90

1.52 (3.96%)

06:15
08/19/19
08/19
06:15
08/19/19
06:15
Downgrade
East West Bancorp rating change  »

East West Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARMK

Aramark

$37.07

-0.07 (-0.19%)

06:14
08/19/19
08/19
06:14
08/19/19
06:14
Upgrade
Aramark rating change  »

Aramark upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SONO

Sonos

$11.90

0.22 (1.88%)

06:13
08/19/19
08/19
06:13
08/19/19
06:13
Upgrade
Sonos rating change  »

Sonos upgraded to Strong…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VWAGY

Volkswagen

$0.00

(0.00%)

06:13
08/19/19
08/19
06:13
08/19/19
06:13
Periodicals
Volkswagen, SEC ordered to seek settlement on fraud allegations, WSJ reports »

Volkswagen and the SEC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WLL

Whiting Petroleum

$8.61

0.36 (4.36%)

06:12
08/19/19
08/19
06:12
08/19/19
06:12
Downgrade
Whiting Petroleum rating change  »

Whiting Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 08

    Oct

  • 09

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.